Massing U - Search Results

1

Alkylphosphocholine-induced glioma cell death is BCL-X(L)-sensitive, caspase-independent and characterized by massive cytoplasmic vacuole formation.

Naumann U, Wischhusen J, Weit S, Rieger J, Wolburg H, Massing U, Weller M. Naumann U, et al. Among authors: massing u. Cell Death Differ. 2004 Dec;11(12):1326-41. doi: 10.1038/sj.cdd.4401503. Cell Death Differ. 2004. PMID: 15389288

2

On the mechanism of alkylphosphocholine (APC)-induced apoptosis in tumour cells.

Oberle C, Massing U, Krug HF. Oberle C, et al. Among authors: massing u. Biol Chem. 2005 Mar;386(3):237-45. doi: 10.1515/BC.2005.029. Biol Chem. 2005. PMID: 15843169

3

Killing tumour cells by alkylphosphocholines: evidence for involvement of CD95.

Matzke A, Massing U, Krug HF. Matzke A, et al. Among authors: massing u. Eur J Cell Biol. 2001 Jan;80(1):1-10. doi: 10.1078/0171-9335-00130. Eur J Cell Biol. 2001. PMID: 11211929

4

Cytotoxic efficacy and influence on cellular phospholipid metabolism of 2-hydroxy- and 2-O-acetyl-octadecylphosphocholines.

Hildenbrand B, Kley JT, Haberstroh F, Freudenberg MA, Azemar M, Unger C, Massing U. Hildenbrand B, et al. Among authors: massing u. Anticancer Res. 2006 Nov-Dec;26(6B):4255-62. Anticancer Res. 2006. PMID: 17201141 Free article.

5

Reduction in human melanoma cell adhesion receptor activity by lysophosphatidylcholine (LPC) treatment - functional characterization and signal pathway analyses.

Alexander M, Schlesinger M, Jantscheff P, Massing U, Bendas G. Alexander M, et al. Among authors: massing u. Int J Clin Pharmacol Ther. 2010 Jul;48(7):478-80. doi: 10.5414/cpp48478. Int J Clin Pharmacol Ther. 2010. PMID: 20557851 No abstract available.

6

The antiproliferative alkylphospholipid S-1-O-phosphocholine-2-N-acetyl-octadecane induces apoptosis in leukemia cell lines.

Krug HF, Oberle C, Matzke A, Massing U. Krug HF, et al. Among authors: massing u. Ann N Y Acad Sci. 2003 Dec;1010:335-8. doi: 10.1196/annals.1299.060. Ann N Y Acad Sci. 2003. PMID: 15033746

7

High throughput screening method for identification of new lipofection reagents.

Regelin AE, Fernholz E, Krug HF, Massing U. Regelin AE, et al. Among authors: massing u. J Biomol Screen. 2001 Aug;6(4):245-54. doi: 10.1177/108705710100600406. J Biomol Screen. 2001. PMID: 11689124

8

Pharmacokinetics and antitumor activity of vincristine entrapped in vesicular phospholipid gels.

Güthlein F, Burger AM, Brandl M, Fiebig HH, Schubert R, Unger C, Massing U. Güthlein F, et al. Among authors: massing u. Anticancer Drugs. 2002 Sep;13(8):797-805. doi: 10.1097/00001813-200209000-00003. Anticancer Drugs. 2002. PMID: 12394263

9

Inhibition of 14-kDa PLA2 by 2-acylamino-alkylphospholipids: the influence of amide acidity.

Kley JT, Unger C, Massing U. Kley JT, et al. Among authors: massing u. Biochim Biophys Acta. 1998 Jun 15;1392(2-3):193-201. doi: 10.1016/s0005-2760(98)00033-2. Biochim Biophys Acta. 1998. PMID: 9630626

10

Synthesis and PLA2-inhibitory properties of 2(R)-acetamido-alkylphosphomethanols with a variable aggregate anchor.

Kley JT, von Kiedrowski G, Unger C, Massing U. Kley JT, et al. Among authors: massing u. Bioorg Med Chem Lett. 1999 Jan 18;9(2):261-4. doi: 10.1016/s0960-894x(98)00721-5. Bioorg Med Chem Lett. 1999. PMID: 10021941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters